ArticleCureus2026
Comparative Assessment of Salivary Neutrophil Gelatinase-Associated Lipocalin Levels (NGAL) Among Subjects With Periodontitis, Liver Cirrhosis, and Healthy Individuals: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeriodontitis and liver cirrhosis are chronic inflammatory disorders characterized by dysregulated immune responses and an increased systemic inflammatory load. Neutrophil gelatinase-associated lipocalin (NGAL) is a neutrophil-derived biomarker implicated in inflammation, tissue injury, and systemic disease. The relationship between salivary NGAL and periodontal health has not been previously studied in individuals with liver cirrhosis.
aimTo evaluate and compare salivary NGAL levels among patients with liver cirrhosis with and without periodontitis, periodontitis alone, and healthy controls. MATERIALS AND
methodsThis cross-sectional study included 40 participants divided into four groups (n=10 each): liver cirrhosis with periodontitis, liver cirrhosis only, periodontitis only, and healthy controls. Periodontal status was evaluated using standardized clinical parameters in accordance with the 2017 American Academy of Periodontology (AAP) classification criteria. Unstimulated whole saliva samples were obtained, and salivary NGAL concentrations were quantified using enzyme-linked immunosorbent assay (ELISA). Intergroup comparisons were analyzed using one-way analysis of variance (ANOVA).
resultsSalivary NGAL levels differed significantly among the study groups (p<0.001). The highest NGAL levels were observed in patients with liver cirrhosis and periodontitis, followed by liver cirrhosis alone, periodontitis alone, and healthy controls. These findings indicate an additive inflammatory effect when periodontal disease coexists with liver cirrhosis.
conclusionSalivary neutrophil gelatinase-associated lipocalin (NGAL) levels were significantly increased in patients presenting with both liver cirrhosis and periodontitis, indicating an enhanced cumulative systemic and periodontal inflammatory burden. Salivary NGAL may serve as a potential non-invasive biomarker linking periodontal inflammation and liver disease. Further longitudinal investigations involving larger sample populations are required to substantiate its clinical applicability and diagnostic utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.